Document is current
Any future updates will be listed below
-
Authors
Betz, Linda T. https://orcid.org/0000-0003-1741-4069
Jacob, Gitta A.
Knitza, Johannes https://orcid.org/0000-0001-9695-0657
Koehm, Michaela https://orcid.org/0000-0002-3579-5574
Behrens, Frank https://orcid.org/0000-0001-8750-7186
-
Funding
Funding for this research was provided by:
GAIA
- License Information
-
More Information
Article History
Received: 27 May 2024
Accepted: 26 August 2024
First Online: 3 September 2024
Competing interests
: L.T.B. and G.A.J. are employed by GAIA, the developer and manufacturer of the intervention described in the study. J.K. has received grants, contracts, consulting fees, travel support, and/or speakers fees from ABATON, Abbvie, AstraZeneca, the German Federal Ministry of Education and Research (BMBF), BMS, Boehringer Ingelheim, Chugai, the German Research Foundation (DFG), the Germany Society of Internal Medicine (DGIM), EIT Health, Galapagos, Gilead, GSK, Janssen, Lilly, Medac, Novartis, Pfizer, Rheumaakademie, Rheumatology Network, Sanofi, Thermo Fisher, UCB, Vila Health, and Werfen, has served on Data Safety Monitoring or Advisory Boards for ABATON, AbbVie, Boehringer Ingelheim, Chugai, Galapagos, Gilead, GSK, Lilly, Medac, Novartis, Pfizer, UCB, Vila Health, and Werthen, and has a leadership or fiduciary role in the Deutsche Gesellschaft für Innere Medizin, Deutsche Gesellschaft für Rheumatologie, and the Digital Rheumatology Network. M.K. and F.B. have no conflicts of interest to declare.
